Nonlinear dynamics of EEG in Alzheimer's disease.
- Published in:
- Drug Development Research, 2002, v. 56, n. 2, p. 57, doi. 10.1002/ddr.10061
- By:
- Publication type:
- Article
Works matching IS 02724391 AND DT 2002 AND VI 56 AND IP 2
Results: 21
1
2
Immunological concept in the treatment of Alzheimer's disease.
- Published in:
- Drug Development Research, 2002, v. 56, n. 2, p. 163, doi. 10.1002/ddr.10072
- By:
- Publication type:
- Article
3
Human Apolipoprotein E concentration in response to diseases and therapeutic treatments.
- Published in:
- Drug Development Research, 2002, v. 56, n. 2, p. 95, doi. 10.1002/ddr.10065
- By:
- Publication type:
- Article
4
Secretases as targets for beta-amyloid lowering drugs.
- Published in:
- Drug Development Research, 2002, v. 56, n. 2, p. 201, doi. 10.1002/ddr.10076
- By:
- Publication type:
- Article
5
Prospects for therapeutic vaccination with glatiramer acetate for neurodegenerative diseases such as Alzheimer's disease.
- Published in:
- Drug Development Research, 2002, v. 56, n. 2, p. 143, doi. 10.1002/ddr.10069
- By:
- Publication type:
- Article
6
Progressive medial temporal lobe changes in Alzheimer's disease revealed by quantitative MRI: potential use for monitoring of drug-related changes.
- Published in:
- Drug Development Research, 2002, v. 56, n. 2, p. 51, doi. 10.1002/ddr.10060
- By:
- Publication type:
- Article
7
Vascular risk factors, ApoE ϵ4 allele, and gender and the risk of Alzheimer's disease: perspectives on prevention.
- Published in:
- Drug Development Research, 2002, v. 56, n. 2, p. 85, doi. 10.1002/ddr.10064
- By:
- Publication type:
- Article
8
Targeting intracellular Aβ42 for Alzheimer's disease drug discovery.
- Published in:
- Drug Development Research, 2002, v. 56, n. 2, p. 194, doi. 10.1002/ddr.10075
- By:
- Publication type:
- Article
9
Immunization for Alzheimer's disease.
- Published in:
- Drug Development Research, 2002, v. 56, n. 2, p. 135, doi. 10.1002/ddr.10068
- By:
- Publication type:
- Article
10
Anti-amyloidogenic activity of cholinergic agents.
- Published in:
- Drug Development Research, 2002, v. 56, n. 2, p. 242, doi. 10.1002/ddr.10079
- By:
- Publication type:
- Article
11
β-Amyloid immunization approaches for Alzheimer's disease.
- Published in:
- Drug Development Research, 2002, v. 56, n. 2, p. 150, doi. 10.1002/ddr.10070
- By:
- Publication type:
- Article
12
Biological markers of Alzheimer's disease.
- Published in:
- Drug Development Research, 2002, v. 56, n. 2, p. 74, doi. 10.1002/ddr.10063
- By:
- Publication type:
- Article
13
Beta-sheet breaker strategy for the treatment of Alzheimer's disease.
- Published in:
- Drug Development Research, 2002, v. 56, n. 2, p. 184, doi. 10.1002/ddr.10074
- By:
- Publication type:
- Article
14
Olfactory functional testing: sensitivity and specificity for Alzheimer's disease.
- Published in:
- Drug Development Research, 2002, v. 56, n. 2, p. 123, doi. 10.1002/ddr.10067
- By:
- Publication type:
- Article
15
Cytosolic protein-protein interactions that regulate the amyloid precursor protein.
- Published in:
- Drug Development Research, 2002, v. 56, n. 2, p. 228, doi. 10.1002/ddr.10078
- By:
- Publication type:
- Article
16
Role of amyloid β peptides in the regulation of central cholinergic function and its relevance to Alzheimer's disease pathology.
- Published in:
- Drug Development Research, 2002, v. 56, n. 2, p. 248, doi. 10.1002/ddr.10080
- By:
- Publication type:
- Article
17
Pharmacogenomic approaches in Alzheimer's disease drug development.
- Published in:
- Drug Development Research, 2002, v. 56, n. 2, p. 67, doi. 10.1002/ddr.10062
- By:
- Publication type:
- Article
18
Therapeutic strategies of Alzheimer's disease through manipulation of Aβ metabolism: a focus on Aβ-degrading peptidase, neprilysin.
- Published in:
- Drug Development Research, 2002, v. 56, n. 2, p. 171, doi. 10.1002/ddr.10073
- By:
- Publication type:
- Article
19
Vitamin B<sub>12</sub>, folate, and Alzheimer's disease.
- Published in:
- Drug Development Research, 2002, v. 56, n. 2, p. 111, doi. 10.1002/ddr.10066
- By:
- Publication type:
- Article
20
Targeting APP metabolism for the treatment of Alzheimer's disease.
- Published in:
- Drug Development Research, 2002, v. 56, n. 2, p. 211, doi. 10.1002/ddr.10077
- By:
- Publication type:
- Article
21
Targeting Alzheimer's disease: Is there a light at the end of the tunnel?
- Published in:
- Drug Development Research, 2002, v. 56, n. 2, p. 45, doi. 10.1002/ddr.10059
- By:
- Publication type:
- Article